- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05848921
Evaluation of Brain Health and Surgical Efficacy in Patients With Carotid Artery Stenosis
April 28, 2023 updated by: Qianyan Liu, Nanjing University of Traditional Chinese Medicine
Research on Changes of Cerebral Vascular Morphology and Cognitive Function in Patients With Carotid Artery Stenosis Before and After Surgery
The purpose of this study is to explore the relationship between the recovery of cerebrovascular morphology and cognitive function before and after surgical treatment in patients with carotid artery stenosis and their preoperative cardiac health status.
And combined with preoperative cognitive status, serum markers, and cardiovascular health evaluation indicators, evaluate and predict the possibility of postoperative neurodegenerative diseases and the level of cerebrovascular health in patients.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to evaluate the brain health status and surgical efficacy of patients with carotid artery stenosis.
Firstly, investigate whether hemodynamic parameters such as blood flow reserve fraction at the carotid artery stenosis site are correlated with white matter hyperintensities and cerebral vascular morphological changes in elderly patients with normal cognition and mild cognitive impairment; Then, when the blood flow of carotid artery has been improved after surgery, compare the cerebrovascular health of patients before surgery and the way of cerebral vascular reconstruction; Combined with the postoperative neuropsychological cognitive test to explore the postoperative cognitive recovery of patients, and combined with the postoperative imaging data and the biomarker in the blood of patients at various stages, to explore the way of cerebral vascular reconstruction and changes in brain structure and function of different groups of patients behind cognitive changes.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bo Yin, phD
- Phone Number: 0086-13857773745
- Email: 76yinbo@163.com
Study Locations
-
-
Zhejiang
-
Wenzhou, Zhejiang, China
- The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU
-
Contact:
- Bo Yin, phD
- Phone Number: 0086-13857773745
- Email: 76yinbo@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
All of the patients of carotid artery stenosis group are in-patients and out-patients in the cardiac surgery department from the research center.
The subjects of control group are recruited from community.
Description
Inclusion Criteria:
- Aged over 50 years old;
- Conscious and capable of completing neuropsychological scales
- Clinical detection of carotid artery stenosis requires surgical treatment;
- Compliant with carotid artery stenting or carotid endarterectomy surgical standards
- Individuals with normal cognition and mild cognitive impairment
Exclusion Criteria:
- Degree of vascular blockage in other intracranial segments ≥ 50%
- Have a history of mental illness, nervous system disease (such as stroke) or brain injury with loss of consciousness for more than five minutes;
- Neurological and psychiatric disorders unrelated to AD (schizophrenia, depression, etc.), post-traumatic stress disorder, obsessive-compulsive disorder, multiple sclerosis, amyotrophic lateral sclerosis)
- Have a history of alcohol or drug abuse
- There are contraindications for magnetic resonance imaging examination
- Those with significant organ dysfunction such as lung, liver, and kidney;
- Patients with intracranial tumors, infectious diseases, and blood system diseases;
- Participating in other clinical studies at the same time
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
HC
Healthy controls
|
Imaging data were collected in a strong magnetic field
Multi dimensional neuropsychological test
|
|
CAS-CN
Carotid Artery Stenosis with cognitive normality
|
Imaging data were collected in a strong magnetic field
Multi dimensional neuropsychological test
|
|
CAS-MCI
Carotid Artery Stenosis with mild cognitive impairment
|
Imaging data were collected in a strong magnetic field
Multi dimensional neuropsychological test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of cerebrovascular morphology before and after treatment
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of Cerebral vessel density, caliber and tortuosity, brain white matter hyperintensity lesion count
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of brain function connectivity before and after operation
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of brain functional connectivity intensity are evaluated by rest stage functional MRI.
DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of brain volume before and after treatment
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months]
|
The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI.
Freesurfer software is used to get the measured value of the volume.
|
before operation; 3-10 Days after operation; 1 month; 6-12months]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of serum marker concentration before and after operation
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of serum marker concentration is evaluated by inflammatory cytokine.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of plasma marker concentration before and after operation
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of plasma marker concentration is evaluated by neurofilament light chain(NFL) protein extracted from plasma.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of executive functions before and after operation evaluated by Trail-Making Test Part A
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of executive functions are first evaluated by Trail-Making Test Part A test.
The minimum value is 0 , and the maximum value is 30.
This test has no clear maximum and minimum values.
If the test completion time exceeds 79 seconds, it means the outcome is abnormal.
The higher scores mean a worse outcome.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of working memory before and after operation evaluated by Forward Digit Span
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of working memory is first evaluated by Forward Digit Span.
The minimum value is 0 , and the maximum value is not clear.
The normal range of results is 7.75±1.47.
The higher scores mean a better outcome.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of working memory before and after operation evaluated by Backward Digit Span
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of working memory is second evaluated by Backward Digit Span.
The minimum value is 0 , and the maximum value is not clear.
The normal range of results is 5.36±1.91.
The higher scores mean a better outcome.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of executive functions before and after operation evaluated by Trail-Making Test Part B
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of executive functions are first evaluated by Trail-Making Test Part B test.
The minimum value is 0 , and the maximum value is 30.
This test has no clear maximum and minimum values.
If the test completion time exceeds 79 seconds, it means the outcome is abnormal.
The higher scores mean a worse outcome.It is a supplement to Trail-Making Test Part A, which is optional for patients who are not familiar with the English alphabetical order
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of executive functions before and after operation evaluated by Digit Symbol Coding score
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of executive functions are second evaluated by Digit Symbol Coding score.
The minimum value is 0 , and the maximum value is not clear.
The normal range of results is 56.53 ± 20.17.
The higher scores mean a better outcome.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Brain evaluate basic cognition before operation
Time Frame: before operation
|
Basic cognition is evaluated by Mini-mental State Examination (MMSE) and Clinical Dementia Rating (CDR) .
For MMSE , The minimum value is 0 , and the maximum value is 30.
The higher scores mean a better outcome.
For CDR , the results are represented by scores of 0,0.5,1,2,3, and the degree of cognitive impairment is classified as normal, suspicious, mild, moderate, and severe
|
before operation
|
|
Change of language function before and after operation evaluated by Language Fluency test
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of language function is evaluated by Language Fluency test.
The minimum value is 0 , and the maximum value is not clear.
The normal range of results is 19.43±4.81.
The higher scores mean a better outcome.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
|
Change of executive functions before and after operation evaluated by Clock Drawing Test
Time Frame: before operation; 3-10 Days after operation; 1 month; 6-12months
|
The change of executive functions is evaluated by Backward Digit Span.
The minimum value is 0 , the maximum value is 4.
|
before operation; 3-10 Days after operation; 1 month; 6-12months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Bo Yin, phD, The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2023
Primary Completion (Anticipated)
December 31, 2025
Study Completion (Anticipated)
December 31, 2025
Study Registration Dates
First Submitted
April 28, 2023
First Submitted That Met QC Criteria
April 28, 2023
First Posted (Actual)
May 8, 2023
Study Record Updates
Last Update Posted (Actual)
May 8, 2023
Last Update Submitted That Met QC Criteria
April 28, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 82071993-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carotid Artery Stenosis
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingOxidative Stress | Carotid Artery Stenosis Asymptomatic | Carotid Artery Stenosis Symptomatic | vonWillebrand Disease
-
Beijing Tiantan HospitalShanghai HeartCare Medical Technology Co., Ltd.RecruitingCarotid Artery Stenting | Carotid Artery StenosisChina
-
Heinrich-Heine University, DuesseldorfRecruitingCarotid Artery Plaque | Carotid Artery Diseases | Carotid Artery Stenosis Asymptomatic | Carotid Artery StenosisGermany
-
Aesculap AGCompletedCarotid Artery Stenosis | Iliac Artery Stenosis | Femoral Artery StenosisGermany
-
Xuanwu Hospital, BeijingChanghai Hospital; Peking Union Medical College Hospital; The Second Hospital... and other collaboratorsRecruitingCarotid Artery Stenting | Carotid Endarterectomy | Best Medical Treatment | Carotid Artery Stenosis AsymptomaticChina
-
Xuanwu Hospital, BeijingGuangdong Provincial People's HospitalRecruitingRadiation-induced Carotid Artery StenosisChina
-
Centre Hospitalier St AnneHôpitaux Universitaires Paris Ile-de-Franc OuestCompleted
-
Acandis GmbHRecruitingCarotid Artery Stenting | Carotid Artery Disease | Embolic Stroke of Undetermined Source | Carotid Artery Thrombosis | Carotid Plaque Imaging | Symptomatic Carotid Artery StenosisGermany
-
Boston Scientific CorporationNot yet recruiting
Clinical Trials on magnetic resonance image
-
Ming KuangUnknownHepatocellular CarcinomaChina
-
Tri-Service General HospitalCompleted
-
Daegu Catholic University Medical CenterCompleted
-
GE HealthcareTerminatedTraumatic Brain InjuryUnited States
-
Hospital Israelita Albert EinsteinUniversity of Sao PauloCompletedExposure to Magnetic Field | Uterine LeiomyomaBrazil
-
Nanjing University of Traditional Chinese MedicineHealth Science Center of Xi'an Jiaotong University; Yuncheng First HospitalNot yet recruitingCoronary Heart Disease | ImageChina
-
Nanjing University of Traditional Chinese MedicineHealth Science Center of Xi'an Jiaotong University; Yuncheng First HospitalNot yet recruitingHeart Valve Diseases | ImageChina
-
Stanford UniversityNational Institutes of Health (NIH); National Institute for Biomedical Imaging...TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityTaihe Hospital; 215 Hospital of Shaanxi NI; Baoji Zhongxin HospitalRecruiting